Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 5/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | CNR2 | P34972 | 1/20 | 0.43 |
| ▸ | RET | P07949 | 1/20 | 0.43 |
| ▸ | KDR | P35968 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6819563 | 1.00 | AOC3 (0.53) | AOC3KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL4406801 | 0.91 | TAAR1 (0.49) | AOC3KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL4406794 | 0.91 | TAAR1 (0.49) | AOC3KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL11650819 | 0.88 | AOC3 (0.53) | AOC3KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL13699528 | 0.88 | ALDH1A1 (0.52) | AOC3KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL8557986 | 0.88 | ALDH1A1 (0.52) | AOC3KDM4EMEN1KMT2ASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL11658826 | 0.87 | AOC3 (0.51) | AOC3KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL11658798 | 0.86 | AOC3 (0.49) | AOC3KDM4EMEN1KMT2ASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL3273754 | 0.86 | ALDH1A1 (0.54) | AOC3KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL9729386 | 0.85 | AOC3 (0.63) | AOC3KDM4EMEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7635776-B2 | Ligands and complex compounds containing the same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-12-22 | — | — | US | disclosed |
| US-20060111572-A1 | Ligands and complex compounds containing the same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-05-25 | — | — | US | disclosed |
| EP-1591439-A1 | LIGANDS AND COMPLEX COMPOUNDS CONTAINING THE SAME | Takasago International Corporation (JP) | 2005-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060111572-A1 | Ligands and complex compounds containing the same | NR0B2, NR4A1, NR0B1 | AOC3 1000/4885KDM4E 2545/4885MEN1 823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.